Search Results for 'treatment hcv'
treatment hcv published presentations and documents on DocSlides.
HCV cure by IFN-free DAAs is associated with increased survival in patients with HCV-related HCC
by jovita
Hansen Dang,. 1,2*. Yee Hui Yeo,. 1*. Satoshi Ya...
Future HCV Treatment Paradigms
by kittie-lecroy
Mark Sulkowski, MD . Professor of Medicine. Medic...
Elbasvir-Grazoprevir in Treatment-Naïve HCV Genotype 1, 4 or 6
by celsa-spraggs
C-EDGE Treatment Naïve (TN). Phase 3. . Treatme...
Care of the Treatment-naive Patient With HCV/HIV Coinfection
by cheryl-pisano
. Case. 47-Year-Old . Man With Asymptomatic HIV ...
Implementing HCV Treatment Programs in Comprehensive HIV Clinics
by medmacr
Todd S. Wills, MD. Martha Friedrich, PhD. SPNS Hep...
The goal of hepatitis C virus (HCV) treatment is a cure (when there is
by amey
Genotype 1, never treated for HCV, no cirrhosis12 ...
Treatment with the second-generation HCV protease inhibitor
by conchita-marotz
Results from SILEN-C1 in HCV genotype-1 treatment...
Role of harm reduction in HCV prevention in France: from r
by tatiana-dople
Bruno Spire & Patrizia Carrieri. How to reduc...
O nline census of drug consumption rooms as a setting to address HCV:
by phoebe-click
 . current practice and future capacity.. Vendul...
Prevention strategies for HIV/HCV co infection
by giovanna-bartolotta
Isabelle Andrieux-Meyer, MD. Médecins Sans Front...
![Treat To Prevent – Millennials, Drugs and Hepatitis C [HCV]](https://thumbs.docslides.com/738712/treat-to-prevent-millennials-drugs-and-hepatitis-c-hcv.jpg)
Treat To Prevent – Millennials, Drugs and Hepatitis C [HCV]
by danika-pritchard
Strategies To Identify and Advance PWID HCV Patie...
HCV Clinical Management TRAINER(S)
by danika-pritchard
IAPAC African Regional Capacity-Building Hub. Bas...
HCV Clinical Management TRAINER(S)
by trish-goza
IAPAC African Regional Capacity-Building Hub. Bas...
HepCare Europe No-one gets left behind: addressing the hidden burden of HCV related advanced liver disease in PWID in the community
by cheryl-pisano
HepCare Europe No-one gets left behind: address...
Darla Peterson, BS, HIV/HCV Program Manager
by catherine
Teri Griep-Langholz, RN, HIV/HCV Program Nurse Cas...
Management of HCV in Co-Infected Patients
by danika-pritchard
Marie-Louise Vachon, MD, . MSc. Division of . Inf...
Update on the HCV Antiviral Pipeline
by natalia-silvester
Todd S. Wills, MD. SPNS HCV Treatment Expansion I...
Sofosbuvir + Ribavirin in HCV Genotype 1
by pamella-moone
NIH SPARE. Phase . 2. Treatment. . Naïve . (unf...
Access to antiviral drugs for treating HCV for HIV-positive
by yoshiko-marsland
AIDS 2016 | 18-22 July 2016 | Durban, South A...
Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6
by pasty-toler
ASTRAL-1. Phase 3. . Treatment. . Naïve & ...
HCV Screening and Linkage to Care
by alexa-scheidler
Program in a Pharmacy Setting. Conveying . the Ur...
An Overview of HIV and HCV in Adolescents and Young Adults
by pamella-moone
Cathryn. L. Samples, MD, MPH, AAHIVS. Director, ...
Is it possible? HCV Elimination
by yoshiko-marsland
Objectives. Define elimination as it relates to i...
Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1
by danika-pritchard
NIAID Retreatment. Phase . 2a . Treatment. . Exp...
Economic Impact of Eliminating HCV
by InLoveWithLife
H. . Razavi. April 13, 2016. HCV Economic impact m...
Sofosbuvir + Ribavirin in HCV Recurrence
by williams
Following Liver Transplantation. Phase 2. Charlton...
The Role of Diagnostics in the Management of HCV and HIV
by zoe
Presented by: Thomas E. Burgess, PhD, DABCC, FAACC...
Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis
by ahmir
ASTRAL-4. Source: Curry MP, et al. N Engl J Med. 2...
Treatment of Hepatitis C in patients with
by tatyana-admore
thalassaemia. . Where . are we now?. Telaprevir ....
Current strategies for the management of treatment naïve a
by min-jolicoeur
Mark S. Sulkowski, MD. Medical Director, Viral He...
Reducing blockages in the pathway to Hepatitis C treatment
by sherrill-nordquist
Emma Burke, PHE. Current London Picture. Findings...
Diagnosis and Treatment of Hepatitis C in the Homeless Popu
by myesha-ticknor
Dr. Joanna Eveland, MS, MD. Clinical Chief for Sp...
